NCT00964366View on ClinicalTrials.gov

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Acne Vulgaris
Interventions
DRUG

clindamycin and benzoyl peroxide

Daily applications, to the randomized side of the face either left or right, of clindamycin and benzoyl peroxide

DRUG

Dapsone gel

Twice-daily applications of dapsone gel

Trial Locations (1)

19008

cyberDERM, Broomall

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Stiefel, a GSK Company

INDUSTRY

NCT00964366 - Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications | Biotech Hunter | Biotech Hunter